Search

And the CC11 FB Contest Winner is… (CC11 Application Deadline, 10/4)

Juvenation

Blogs from JDRF and/or Juvenation

And the CC11 FB Contest Winner is… (CC11 Application Deadline, 10/4)

  • Comments 2

Before we get to announcing the winner, just another quick reminder: Submit a 2011 Children’s Congress (CC11) applications before 5 pm (EDT), on Monday, 10/4! You can do it via the CC11 website or via the Facebook application. If you know someone who might be interested, encourage them to apply ASAP!

Also, check out a blog post about a live CC11 Q&A tonight at 8 pm (EDT). RSVP to attend!

Now back to being excited and getting excited!!!

I have been waiting all summer to find out who was going to win, as I am sure many of you are as well. Keep in mind that even if you didn’t win, your application is still in the running and will be reviewed by volunteer selections committee. Good luck and watch the video below to find out the lucky winner:





Your comment has been posted.   Close
Thank you, your comment requires moderation so it may take a while to appear.   Close
Leave a Comment
  • Post
  • Congrats Madison!!

  • Hi JDRF Advocates! September was an exciting month here in JDRF Advocacy. We discussed a range of topics

Page 1 of 1 (2 items)

ABOUT JUVENATION
Juvenation is a vibrant social network created especially for and by people with type 1 diabetes and their loved ones. More about Juvenation

Terms of Service | Privacy Policy

DONATION
Please consider making a donation to JDRF to support research toward better treatments and a cure for type 1 diabetes.

SUPPORT
For help on Juvenation you can view answers to common support questions or contact us.


JDRF is the worldwide leader for research to prevent, better treat, and ultimately cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. More about JDRF Juvenation is funded through an educational grant from Novo Nordisk through its Changing Diabetes© leadership initiative. More about Novo Nordisk